Subgroup of colorectal cancer patients ID'd: Do poorly, could benefit from immunotherapy
While the medical community agrees that immune cells inside a tumor leads to improved health outcome, for a subset of colorectal cancer patients, having too much of a good thing—too many immune cells—is a strong predictor ...
Sep 16, 2019
0
2